Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.
Benarroch
Eduardo
E
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Benarroch.eduardo@mayo.edu
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism*; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism* / Q000627:therapeutic use; D063388:Endocannabinoids; D006801:Humans; D009415:Nerve Net / Q000187:drug effects / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D011485:Protein Binding / Q000502:physiology; D043882:Receptors, Cannabinoid / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid